Skip to content
National Cancer Institute
U.S. National Institutes of Health
| www.cancer.gov
In English |
En español
Search
NCI Home
Cancer Topics
Clinical Trials
Cancer Statistics
Research & Funding
News
About NCI
Clinical Trials Search Results
Quick Links
Director's Corner
Dictionary of Cancer Terms
NCI Drug Dictionary
Funding Opportunities
NCI Publications
Advisory Boards and Groups
Science Serving People
Español
Questions about cancer?
1-800-4-CANCER
LiveHelp® online chat
NCI Highlights
Virtual and Standard Colonoscopy Both Accurate
Denosumab May Help Prevent Bone Loss
Past Highlights
Results:
1 -2 of 2
Show
10
25
50
100
200
results per page
View Search Criteria
|
Help With Results
Sort By:
Phase of Trial
Title
Type of Trial
Status of Trial
Age Range
Sponsor of Trial
Protocol IDs
Version:
Health Professional
Patient
Format:
Short
------
Short
Medium
Long
Custom
Last Modified:
7/27/2007
 
First Published:
4/1/1998
1.
Phase II Study of High-Dose Methotrexate Plus High-Dose Zidovudine and Radiotherapy in Patients with HIV-Related Primary Central Nervous System Lymphoma
Phase
Type
Status
Age
Sponsor
Protocol IDs
Phase II
Treatment
Active
18 and over
Other
ITA-GICAT-POS1
EU-97018, NCT00003261
Last Modified:
4/15/2008
 
First Published:
11/22/2004
2.
Pilot Study of High-Dose Zidovudine and Valganciclovir With or Without Bortezomib or EPOCH-R (Comprising Etoposide, Doxorubicin, Vincristine, Prednisone, Cyclophosphamide, and Rituximab) or Observation or HAART Only in Patients With Multicentric Castleman's Disease Associated With Kaposi's Sarcoma-Associated Herpesvirus
Phase
Type
Status
Age
Sponsor
Protocol IDs
No phase specified
Treatment
Active
12 and over
NCI
NCI-04-C-0275
NCT00099073
Select All on One Page
NCI Home
|
Images Version
|
Contact Us
|
Policies
|
Accessibility
|
Viewing Files
|
FOIA
|
Site Help
|
Site Map
A Service of the National Cancer Institute